Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sianny Herawati has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chronic Myeloid Leukemia in a Female Child with Philadelphia Chromosome Negative: A Case Report

    by Pande Made Bunga Ningayu, I Nyoman Wande, Ni Nyoman Mahartini, Sianny Herawati

    Chronic Myeloid Leukemia (CML) in pediatric patients is rare, with an annual incidence of approximately 0.6-1.0 cases per million in children under 15 years of age, with Philadelphia chromosome-negative cases occurring in about 5% of instances. This case report describes an 11-year-old female with Philadelphia chromosome-negative CML. The patient's clinical presentation included abdominal distension and firmness, accompanied by fever. Physical examination revealed pale conjunctivae, hepatomegaly with the liver palpable 10 cm below the costal margin, and splenomegaly classified as Schuffner grade IV. Laboratory findings indicated hyperleukocytosis, neutrophilia, lymphocytosis, monocytosis, eosinophilia, basophilia, thrombocytosis, and anemia. Peripheral blood smear results raised suspicion of acute leukemia, while bone marrow aspiration findings were consistent with chronic-phase CML. Immunophenotyping confirmed a myeloid lineage. Philadelphia chromosome testing returned a negative result. In this patient, microscopic examination of the peripheral blood smear revealed normochromic normocytic anemia, hyperleukocytosis, and thrombocytosis, raising suspicion of chronic leukemia. Bone marrow aspiration demonstrated hypercellularity, reduced erythroid activity, increased myeloid and megakaryocyte activity, and the presence of all myeloid series (from myeloblasts to segmented cells), with 8% myeloblasts, consistent with chronic-phase CML. This case contributes to the understanding of the clinical presentation and diagnostic challenges of Philadelphia chromosome-negative CML in pediatric patients.

  • Open Access

    Integrating Routine Hematological and Extended Inflammatory Parameters as a Novel Approach for Timely Diagnosis and Prognosis in Sepsis Management

    by Sianny Herawati, I Ketut Agus Somia, Sully Kosasih, I Nyoman Wande, Jethro Felim, I Made Dwi Payana

    Sepsis is one of the major causes of morbidity and mortality in hospitals, especially in low- and middle-income countries, and represents a challenge to health care providers to carry out early detection, and accurate diagnosis and prognosis with cost-effective diagnostic tools. An observational prospective study was conducted from December 2021 to December 2022 to investigate the extended inflammatory parameters (EIPs) for sepsis management and analyze the survival of septic patients in the emergency unit, intensive care unit (ICU) and inpatient ward. Patients suspected of having sepsis underwent a sequential organ failure assessment (SOFA) evaluation and had blood drawn for complete blood counts (CBCs). Significant changes were observed in various CBC parameters and EIPs, and the sepsis group was followed up with for 30-day mortality. The study highlighted a significant difference yet strong discriminatory power to differentiate sepsis with an AUC of 0.924 against the non-sepsis group and an AUC of 0.991 against the healthy control group using combination of white blood cells and EIPs. Furthermore, the study showed good predictive ability for 30-day mortality with a hazard ratio of 2.311. In summary, this study provides evidence that the utilization of EIPs may be valuable in diagnosing and predicting patient outcomes, and thus will be beneficial for sepsis management in the hospital.


  • Open Access

    Therapeutic Plasma Exchange in Crisis Myasthenia Gravis with Pregnancy

    by Anak Agung Ayu Lydia Prawita, Ida Ayu Putri Wirawati, Sianny Herawati

    Myasthenic Crisis (MC) is a clinical diagnosis defined by respiratory failure in patients with Myasthenia Gravis (MG). As MG symptoms worsen, the weakness of the respiratory muscles or upper airway can increase so much that it causes difficulty swallowing or breathing, resulting in respiratory distress. One of the triggers for a myasthenic crisis is pregnancy. In this case, the patient was undergoing a second pregnancy with a gestational age of 28-29 weeks and had been diagnosed with MG 4 years ago. The female patient, 27 years old, had complaints of shortness of breath, difficulty chewing, and weakness in the extremities. During her stay in the hospital, the patient's condition worsened and she experienced a myasthenic crisis. Therapeutic Plasma Exchange (TPE) was administered to the patient 3 times and the patient's had clinical improvement. The patient was discharged with pyridostigmine and methylprednisolone therapy. Therapeutic plasma exchange is a safe and effective procedure for the management of myasthenia gravis during pregnancy. Prompt diagnosis and proper management can reduce morbidity in myasthenia gravis, especially those in crisis.

  • Open Access

    Ascorbic acid and calcitriol reduce TNF-α to improve the viability of modified McFarlane random skin flaps in Wistar rats

    by Rosalyn Devina Santoso, Agus Roy Rusly Hariantana Hamid, Tjokorda Gde Bagus Mahadewa, I Gusti Putu Hendra Sanjaya, Ni Nyoman Sri Budayanti, Sianny Herawati

    Link of Video https://youtu.be/8UIEdUv8za8 Introduction: Distal flap necrosis is one of the most common complications in flap procedure. Ascorbic acid (vitamin C) is one of the most widespread antioxidants available, while calcitriol, a metabolite of vitamin D, has anti-inflammatory and antioxidant properties. The purpose of this study was to determine the effect of ascorbic acid and calcitriol on the viability of Modified McFarlane random skin flaps in Wistar rats and its mechanism through suppression of proinflammatory cytokine Tumor Necrosis Factor-α (TNF-α). Methods: An experimental study used 28 Wistar rats, by creating a caudally based 3 cm x 9 cm Modified McFarlane random skin flap and divided into four groups. The first group was injected with 200 mg/kg/day ascorbic acid, the second group with 2μg/kg/day calcitriol, and the third group with 200 mg/kg/day ascorbic acid combined with 2μg/kg/day calcitriol was injected two hours after flap elevation for seven days, respectively. The control group was not given any intraperitoneal injection. After seven days, the percentage of flap viability rate was measured and tissue sampling was performed to measure the amount of capillary density and TNF-α in all groups. Results: The higher percentage of viable flap area was found in all treatment groups, the highest in the ascorbic acid group 80.63% (p<0.001). The highest capillary density was found in ascorbic acid combined with the calcitriol group (27/visual field, p<0.001) compared to all groups. It was also found that the amount of TNF-α in the tissue was lowest in the group administered by ascorbic acid combined with calcitriol compared to all groups 57.38 ng/L and 0.62 nmol/mL respectively compared to all groups (p<0.001). The higher percentage of viable flap area was correlated with a lower amount of TNF-α (p0.05). Conclusion: Ascorbic acid in combination with calcitriol improves the viability of Modified McFarlane random skin flaps by lowering TNF-α levels.


  • Open Access

    Administration of botulinum toxin a and vascular endhotelial growth factor reduce norepinephrine levels and increase viability of modified mcfarlane flap in wistar rat

    by I Gusti Ayu Putri Purwanthi, Agus Roy Rusly Hariantana Hamid, Tjokorda Gde Bagus Mahadewa, I Made Suka Adnyana, I Gusti Putu Hendra Sanjaya, Sianny Herawati, Gede Wara Samsarga

    Local hyperadrenergic states after a random flap elevation mediated by humoral vasoconstrictors can lead to flap necrosis. This study aimed to evaluate the effect of Botulinum Toxin A (BoNT-A) on reducing levels of Norepinephrine (NE) as the main humoral vasoactive substance, as well as its additive effect with Vascular Endothelial Growth Factor (VEGF) in increasing the viability of random flap. 28 Wistar Rats with Caudally Based Modified McFarlane Flap were divided into four groups. Group I received BoNT-A 3 days before flap elevation, group II received VEGF immediately after flap elevation, group III received a combination of BoNT-A and VEGF, group IV was a control group. Result in this study NE levels lowest was found in the BoNT-A+VEGF combination group (94.63 ± 5 .25 ng/ml, p<0.05 in group I, p<0.01 in groups II and IV). The highest value of FVR was shown in the BoNT-A+VEGF combination group (93.37 ± 2.19 %, p < 0.05 in group I, p < 0.01 in groups II and IV). Meanwhile, the increase in flap viability in the VEGF group was not statistically significant. So Conclusion administration of BoNT-A in combination with VEGF can increase the viability of random flaps by decreasing NE levels.

  • Open Access

    Pancreatitis in Acute Lymphoblastic Leukemia

    by Putu Yudi Adnyani, I Nyoman Wande, Sianny Herawati

    Pancreatitis is inflammation of the pancreatic parenchyma and diagnosed based on symptoms of heartburn accompanied by increased levels of pancreatic enzymes. Acute pancreatitis in acute lymphoblastic leukemia in addition to being caused by therapy can also be caused by other factors. 13-year-old female patient with a diagnosis of acute lymphoblastic leukemia complained of heartburn which was felt through to the back. Patients also experience nausea, vomiting, decreased appetite, difficulty in bowel movements, and fever. Physical examination found an increase in body temperature, anemic eyes, multiple neck gland enlargement, and enlargement of the liver. The results of complete blood tests showed leukocytosis, anemia, and thrombocytopenia. The results of examination of bone marrow aspiration show a picture of the bone marrow in accordance with acute lymphoblastic leukemia (ALL-L2). Clinical chemistry tests showed an increase in amylase, lipase, SGOT, BUN, creatinine, LDH, ferritin, calcium, and procalcitonin. The patient has never received chemotherapy for the ALL. Acute pancreatitis in ALL in addition to being caused by administration of leukemia can also be caused by sepsis conditions which are complications of the ALL. ALL patients who experience acute pancreatitis in this case show a poor prognosis.

  • Open Access

    A child with Down Syndrome and Type 2 Diabetic Mellitus

    by Betti Bettavia Hartama Pardosi, Sianny Herawati, Ni Kadek Mulyantari

    Down Syndrome (DS) is one of the common chromosomal disorders that raise mental retardation. It is known that DS patients have an autoimmune disorder affecting the endocrine and non-endocrine organs. It is a rare occurrence of type 2 Diabetes Mellitus (type 2 DM) disease in children with DS. Type 2 DM occurs due to impaired insulin secretion and excessive hepatic glucose production, unlike type 1 DM, caused by the destruction of íŸ-cells in autoimmune Langerhans. A 10-year-old girl patient was referred from Tabanan Hospital to Sanglah Hospital, Denpasar. Patients were admitted to the hospital with decreased consciousness, treated for four days, and observed in ICU for 2 days. Vomiting twice, no seizures, urinating normally. No significant past medical history was found. Physical examinations showed a typical Mongolian face, short neck, expanded occipital area, small eyes, and a mouth with a prominent tongue. Laboratory data revealed fasting blood glucose of 473 mg/dL and an HbA1C level of 12.6%. Urinalysis showed ketone 3+. The C-peptide test showed a reasonably good íŸ pancreas cell function. Down syndrome is associated with autoimmune diseases, including type 1 diabetes. The exact number of down syndrome cases with type 2 DM remains unknown; however, it was known that the case is infrequent.

  • Open Access

    Eosinophil Count, Neutrophil-to-Lymphocyte Ratio, and Pentraxin-3 Level as Predictors of Clinical Severity in SARS-CoV-2 Patients

    by I Made Dharma Pramana, Sianny Herawati, Cokorda Agung Wahyu Purnamasidhi, Ni Kadek Mulyantari, A. A. Wiradewi Lestari, I Nyoman Wande

    Background: New biomarkers are urgently needed to predict the severity of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eosinophil count and neutrophil-to-lymphocyte ratio (NLR) are new biomarkers for the severity of viral infection. Pentraxin 3 (PTX3) is a natural humoral immune mediator that can bind to viruses, complement, and apoptotic cells, and can trigger T-helper type 1 (Th1) to produce pro-inflammatory cytokines and their levels increase depending on the severity of the disease. Materials and Methods: This was a case-control study consisting of 66 patients infected with SARS-CoV-2 who were divided into critical patients (Group C) and noncritical patients (Group N). We obtained lab samples from the subjects upon admission. We then analyzed the data using the Mann–Whitney U test, receiving operator characteristic (ROC) analysis, and chi-square test with odds ratio (OR) to test the hypothesis. Results: Median eosinophil count, NLR, and PTX3 levels in Group C were 0 ×103/µL, 13.53 and 608.73 pg/mL, compared to 0.11 ×103/µL, 1.94 and 28.50 pg/mL in Group N. The ROC analysis showed good predictive ability for eosinophil count, NLR, and PTX3 with area under the curve (AUC) of 0.913, 0.988, and 0.942 to predict coronavirus disease-2019 (COVID-19) severity. At the cutoff eosinophil count of 0.035 × 103/µL, NLR 4.13 and PTX3 114.51 pg/mL, the OR values were 17.5, 320, and 72.5 (P < 0.05) with a sensitivity of 84.8%, 97.0%, and 90.9% and specificity 75.8%, 90.9%, and 87.9%. Conclusions: Eosinophil count, NLR, and PTX3 levels can be used as predictors of clinical severity in SARS-CoV-2. Eosinophil count of 4.13, and PTX3 level >114.51 pg/mL are risk factors for critical conditions for COVID-19.


  • Open Access

    Aberrant expression of CD5 in a B-lineage Acute Lymphoblastic Leukemia (ALL): a case report

    by Ni Ketut Puspa Sari, Ni Nyoman Mahartini, Ni Kadek Mulyantari, Anak Agung Ayu Lydia Prawita, Ni Komang Krisnawati, I Putu Yuda Prabawa, Sianny Herawati, Made Minarti Witarini Dewi, Ekarini Katharina Yunarti Nabu

    Background: CD5 is expressed in several B-lymphocyte malignancies, including Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), but CD5 positive B-cell lineage Acute Lymphoblastic Leukemia (ALL) is extremely rare. Aberrant T-cell antigen expression is associated with poor prognosis and is a useful marker to identify patients at increased risk. This case report aims to elaborate on the aberrant expression of CD5 in B-lineage ALL. Case Presentation: A 16-years-old male presented with a history of gum bleeding and abdominal pain of 7 days with associated fever, weakness and bone pain of 2-month duration. The bone marrow aspiration showed lymphoblast 30 % with the positive vacuole. In addition, the immunophenotyping test indicates for leukemia B-lineage with expression CD19, CD10, HLA-DR, CD 34, and there is the aberrant expression of CD5. Conclusion: Aberrant expression CD5 in cases of ALL B lineage is very rare. This can be associated with a poor prognosis.

  • Open Access

    Gaucher's disease in a 4-year-old child at Sanglah General Hospital, Bali, Indonesia

    by Ekarini Katharina Yunarti Nabu, Ni Nyoman Mahartini, Ida Ayu Putri Wirawati, Sianny Herawati, Betti Bettavia Hartama Pardosi, Ni Komang Krisnawati, Anak Agung Ayu Lydia Prawita, I Putu Yuda Prabawa

    Background: Gaucher's disease is a rare Lysosomal Storage Disorder (LSD) caused by the accumulation of glucosylceramide/glucocerebroside. There are several types of Gaucher, such as non-neuronopathic, infantile-onset neuronopathic and juvenile-onset neuronopathic. This case study aims to evaluate Gaucher's disease in a 4-year-old child at Sanglah General Hospital, Bali, Indonesia. Case Presentation: A 4-years-old child is admitted to the hospital with a chief complaint of enlargement in the stomach. There is no pain in the bone as well as no sign of bleeding. The patient's parents are blood relatives. On physical examination, hepatosplenomegaly was found, a decreased level of hemoglobin and thrombocytes was also found in the hematology examination. There was an increase of level ferritin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), globulin, and triglycerides from chemistry evaluation, also decreasing level total cholesterol. From bone marrow aspiration was found an increase of activity of the megakaryocyte and Gaucher's cell. The result from enzyme examination found a decrease of activity enzyme ?-glucosidase. Suggestion to this patient is Enzyme Replacement Therapy (ERT). Conclusion: Gaucher's disease is a rare case and difficult to diagnose. A biochemistry examination using the enzyme -glucosidase is necessarily needed as well as a suggestion of ERT.